Tech Company Financing Transactions
Vapogenix Funding Round
On 9/15/2016, Vapogenix secured $8 million in funding from private investors.
Transaction Overview
Company Name
Announced On
9/15/2016
Transaction Type
Venture Equity
Amount
$7,978,130
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 35 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8285 El Rio St. 170
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Heather Giles
Chief Financial Officer
Clarice Motter
Browse more venture capital transactions:
Prev: 9/15/2016: Appdiff venture capital transaction
Next: 9/15/2016: Lucid Software venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs